Clinical trials
Active, not recruiting Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
225 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 10 |
| 2021 | 12 |
| 2022 | 15 |
| 2023 | 29 |
| 2024 | 26 |
| 2025 | 72 |
| 2026 | 42 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 225 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 20 |
| University of Colorado, Denver | 8 |
| Amgen | 6 |
| Novo Nordisk A/S | 5 |
| Pfizer | 5 |
| Hoffmann-La Roche | 4 |
| AstraZeneca | 3 |
| Dong Peng | 3 |
| First Affiliated Hospital of Chongqing Medical University | 3 |
| Kailera | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 225 |
| Obesity | 205 |
| Diabetes Mellitus, Type 2 | 26 |
| Weight Loss | 21 |
| Hypertension | 18 |
| Diabetes Mellitus | 16 |
| Insulin Resistance | 12 |
| Body Weight | 10 |
| Cardiovascular Diseases | 10 |
| Prediabetic State | 10 |
Trials
Showing 26 to 50 of 225. Each trial links to its page on Pharma Observatory.
125 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.